Chronic Lymphocytic Leukemia

Overview

Written by authors from the world’s most prominent cancer centers, Chronic Lymphocytic Leukemia supplies a comprehensive, up-to-date picture of CLL and how to better treat patients inflicted with the disease.

New information on developments in the molecular pathogenesis of this disease impacts how physicians approach and treat patients with CLL. The various predisposing factors for the disease are addressed ...

See more details below
Available through our Marketplace sellers.
Other sellers (Hardcover)
  • All (7) from $129.97   
  • New (4) from $129.97   
  • Used (3) from $150.23   
Close
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any BN.com coupons and promotions
$129.97
STO
Seller since 2010

Feedback rating:

(400)

Condition:

New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

New
US Edition Book In Mint condition. Shipping with Trackable Method.

Ships from: Houston, TX

Usually ships in 1-2 business days

  • Standard, 48 States
  • Standard (AK, HI)
  • Express, 48 States
  • Express (AK, HI)
$130.56
Seller since 2008

Feedback rating:

(4535)

Condition: New
New Book. Shipped from UK within 4 to 14 business days. Established seller since 2000.

Ships from: Horcott Rd, Fairford, United Kingdom

Usually ships in 1-2 business days

  • Standard, 48 States
  • Standard (AK, HI)
$137.76
Seller since 2007

Feedback rating:

(23584)

Condition: New
BRAND NEW

Ships from: Avenel, NJ

Usually ships in 1-2 business days

  • Canadian
  • International
  • Standard, 48 States
  • Standard (AK, HI)
$145.99
Seller since 2009

Feedback rating:

(10664)

Condition: New
New Book. Shipped from US within 10 to 14 business days. Established seller since 2000.

Ships from: Secaucus, NJ

Usually ships in 1-2 business days

  • Standard, 48 States
  • Standard (AK, HI)
Page 1 of 1
Showing All
Close
Sort by
Sending request ...

Overview

Written by authors from the world’s most prominent cancer centers, Chronic Lymphocytic Leukemia supplies a comprehensive, up-to-date picture of CLL and how to better treat patients inflicted with the disease.

New information on developments in the molecular pathogenesis of this disease impacts how physicians approach and treat patients with CLL. The various predisposing factors for the disease are addressed along with current and future treatment modalities and recommended standards of care.

Key features include:


  • introduction by Kanti Rai, MD who developed the Rai Classification and Staging system used in CLL diagnosis
  • CLL in relationship to gene expression profiling and molecular abnormalities
  • familial clustering and gene predisposition
  • targeted therapy trials
  • clinical patient management based upon stage and progression of disease
Read More Show Less

Product Details

  • ISBN-13: 9781420068955
  • Publisher: CRC Press
  • Publication date: 10/24/2008
  • Edition number: 1
  • Pages: 312
  • Product dimensions: 0.70 (w) x 1.00 (h) x 0.90 (d)

Meet the Author

SUSAN O’BRIEN is Professor of Medicine and Clinical Consultant and Special Assistant to the Physician-in-Chief, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA. She received her M.D. from the University of Medicine and Dentistry of New Jersey Medical School, Newark, New Jersey, USA. In recognition of her contributions to the medical field, Dr. O’Brien has been named on the lists of "America’s Top Physicians" and "The Best Doctors in America." She is an experienced writer of and contributor to numerous books, journals, manuals, teaching aids, and other publications, and a frequent invited speaker at conferences, seminars, and conventions. Dr. O’Brien is a member of numerous professional organizations, and she currently serves as Chair of the National Comprehensive Cancer Network’s Chronic Myelogenous Leukemia Guidelines Panel. To fund her research in leukemia, she has received grants and funding from Ortho-McNeil and Berlex, Inc., among others.

JOHN G. GRIBBEN is Professor of Experimental Cancer Medicine and Director of Stem Cell Transplantation, Barts and the London School of Medicine, and Medical Director of the North East London Cancer Research Network, London, UK. He received his M.D. from the University of Glasgow, Glasgow, UK. Professor Gribben leads the newly established Centre for Experimental Cancer Medicine, which facilitates translational cancer research from "basic scientific discovery" to "novel approaches to care of patients with cancer." Dr. Gribben is a founding member of the Chronic Lymphocytic Leukemia Consortium and is also a current member or fellow of several professional organizations, including the American Society for Clinical Investigation and the Academy of Medical Sciences. Dr. Gribben is the author of more than 300 articles and chapters on the subjects of stem cell transportation for cancer treatment, tumor antigens and B cell malignancies, and leukemia and lymphoma.

Read More Show Less

Table of Contents

1. Origin and Nature of the CLL Cell. 2. Gene Expression Profiling. 3. Molecular Pathogenesis. 4. CLL and the B Cell Receptor. 5. Epidemiology and Familial CLL. 6. Apoptosis Disregulation in CLL. 7. Differential Diagnosis, Staging, and Prognostic Factors. 8. Frontline Therapy. 9. Treatment of Relapsed Disease. 10. New Therapies. 11. Transplant in CLL. 12. Gene therapy, vaccines and immune modulation. 13. PLL. 14. CLL Specific Complications: Autoimmunity and Richter’s Syndrome. 15. Infections in CLL.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)